Holen Sie sich die Stockscreener-App
629.35
1.97%
12.15
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$617.20
Offen:
$616.77
24-Stunden-Volumen:
537.92K
Relative Volume:
1.01
Marktkapitalisierung:
$50.25B
Einnahmen:
$4.30B
Nettoeinkommen (Verlust:
$1.06B
KGV:
48.13
EPS:
13.076
Netto-Cashflow:
$1.04B
1W Leistung:
-2.37%
1M Leistung:
-11.86%
6M Leistung:
-5.21%
1J Leistung:
+36.89%
1-Tages-Spanne:
$606.04
$636.05
1-Wochen-Bereich:
$606.04
$651.57
52-Wochen-Spanne:
$356.14
$769.98
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX vs TMO, DHR, A, WAT
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
629.35 | 49.28B | 4.30B | 1.06B | 1.04B | 13.08 |
|
TMO
Thermo Fisher Scientific Inc
|
504.82 | 191.54B | 44.56B | 6.73B | 6.29B | 17.74 |
|
DHR
Danaher Corp
|
212.58 | 151.94B | 24.57B | 3.60B | 5.25B | 5.0475 |
|
A
Agilent Technologies Inc
|
125.81 | 35.32B | 6.95B | 1.30B | 1.15B | 4.5696 |
|
WAT
Waters Corp
|
323.37 | 31.37B | 3.17B | 642.63M | 539.81M | 10.77 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-10-31 | Hochstufung | Stifel | Hold → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-08-05 | Bestätigt | BTIG Research | Buy |
| 2025-07-01 | Eingeleitet | Jefferies | Buy |
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
Assetmark Inc. Has $32.74 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (IDXX) Announces Board Changes Ahead of 2026 Annual Meeting - GuruFocus
Idexx Laboratories Announces Director Retirement and Board Changes - TipRanks
Idexx Labs exec Fennell sells $7.3m in shares - Investing.com
Agree To Purchase Idexx Laboratories At $560, Earn 8.5% Annualized Using Options - Nasdaq
Wealthfront Advisers LLC Buys 2,463 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories to Present at Two Institutional Investor Conferences - 01net
4,049 Shares in IDEXX Laboratories, Inc. $IDXX Purchased by Krilogy Financial LLC - MarketBeat
Rhumbline Advisers Reduces Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Caprock Group LLC Invests $5 Million in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories Inc(IDXX.US) Officer Sells US$7.34 Million in Common Stock - 富途牛牛
Insider Selling: IDEXX Laboratories (NASDAQ:IDXX) EVP Sells 11,345 Shares of Stock - MarketBeat
Baron Partners Fund is Leveraging IDEXX Laboratories’ (IDXX) Long-Term Growth Drivers - Insider Monkey
IDEXX Laboratories, Inc. $IDXX Shares Sold by Jensen Investment Management Inc. - MarketBeat
Midwest Trust Co Purchases 12,179 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Stock Position Decreased by RFG Advisory LLC - MarketBeat
Here's Why Idexx Laboratories (IDXX) is a Strong Growth Stock - Yahoo Finance
Aug Swings: Can IDEXX Laboratories Inc keep up with sector leadersJuly 2025 Breakouts & Risk Controlled Stock Pick Alerts - baoquankhu1.vn
IDEXX Laboratories, Inc. $IDXX Shares Sold by ProShare Advisors LLC - MarketBeat
Candriam S.C.A. Has $14.68 Million Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Piper Sandler Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Cuts Target Price to $750 - 富途牛牛
Piper Sandler Adjusts Price Target on IDEXX Laboratories to $750 From $775, Maintains Neutral Rating - marketscreener.com
Oppenheimer Asset Management Inc. Sells 3,458 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
State of Michigan Retirement System Lowers Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. (IDXX): A Bull Case Theory - Finviz
Envestnet Asset Management Inc. Trims Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories, Inc. $IDXX Shares Sold by IQ EQ FUND MANAGEMENT IRELAND Ltd - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Upgraded to Strong-Buy at Wall Street Zen - MarketBeat
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX), Qiagen (QGEN) and InnovAge Holding (INNV) - The Globe and Mail
Is IDEXX’s Innovation-Fueled 2025 Results And 2026 Outlook Altering The Investment Case For IDXX? - Sahm
Barclays Adjusts Price Target on IDEXX Laboratories to $800 From $850, Maintains Overweight Rating - marketscreener.com
4 Analysts Have This To Say About IDEXX Laboratories - Benzinga
IDEXX Laboratories (IDXX) Positioned to Benefit from Growing Aging Pet Market - Finviz
Fidelity Growth Strategies Fund Avoids IDEXX Laboratories (IDXX) Due to Questionable Growth Durability - Insider Monkey
BI Asset Management Fondsmaeglerselskab A S Has $28.77 Million Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Bessemer Group Inc. Sells 29,560 Shares of IDEXX Laboratories, Inc. $IDXX - MarketBeat
Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Idexx Laboratories (IDXX) and West Pharmaceutical Services (WST) - The Globe and Mail
Barclays Lowers Price Target on IDEXX Laboratories to $800 From $850 - marketscreener.com
Idexx Laboratories executive vice president sells $4.6 million in stock - MSN
IDEXX: A Great Business Trapped By A Demanding Valuation (NASDAQ:IDXX) - Seeking Alpha
Hantz Financial Services Inc. Decreases Stake in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Alta Capital Management LLC Cuts Stock Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Atlantic Union Bankshares Corp Takes Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Rep. April McClain Delaney Sells Off Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Analysts Offer Insights on Healthcare Companies: Idexx Laboratories (IDXX) and Lonza Group (OtherLZAGY) - The Globe and Mail
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $730 to $805 - 富途牛牛
IDEXX Laboratories Analysts Cut Their Forecasts Following Q4 Results - Benzinga
Stifel Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $775 - 富途牛牛
Roku To Rally Around 33%? Here Are 10 Top Analyst Forecasts For Tuesday - Benzinga
Jefferies Adjusts Price Target on IDEXX Laboratories to $820 From $830 - marketscreener.com
BTIG Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Maintains Target Price $800 - 富途牛牛
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
0.77%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):